Estimations des analystes de Wall Street pour Savara Inc. (SVRA): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 9 |
| Conserver | 2 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 11 |
| Note moyenne (1-5) | 0.82 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.16 | ||
| 2026-08-11 | $-0.16 | $-0.14 | -13.3% |
| 2026-05-12 | $-0.15 | $-0.14 | -7.1% |
| 2026-03-13 | $-0.13 | $-0.12 | -8.3% |
| 2025-11-12 | $-0.14 | $-0.13 | -7.7% |
| 2025-08-13 | $-0.14 | $-0.12 | -16.7% |
| 2025-05-13 | $-0.12 | $-0.12 | +0.0% |
| 2025-03-27 | $-0.13 | $-0.11 | -18.2% |
Ratios de valorisation
| Prix / Valeur comptable | 9.09 |
| EV / EBITDA | -7.83 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $400000 | 0 | 0 | 0 | $257000 | 0 | 0 | 0 | 0 | 0 |
| Coût des Ventes | 0 | $363000 | $526000 | $38.8M | $35.0M | $29.0M | $27.9M | $44.3M | $78.0M | $245000 |
| Marge Brute | $400000 | -$363000 | -$526000 | -$38.8M | -$34.8M | -$29.0M | -$27.9M | -$44.3M | -$78.0M | -$245000 |
| R&D | $8.2M | $18.5M | $37.2M | $38.8M | $35.0M | $29.0M | $27.9M | $44.3M | $78.0M | $81.4M |
| Frais Généraux | $2.8M | $11.1M | $10.7M | $12.9M | $12.0M | $12.3M | $10.9M | $15.7M | $25.0M | $42.1M |
| Charges Opérationnelles | $11.3M | $30.0M | $48.4M | $40.2M | $14.5M | $12.5M | $11.0M | $15.7M | $25.2M | $123.3M |
| Résultat Opérationnel | -$10.9M | -$30.0M | -$70.0M | -$79.0M | -$49.3M | -$41.5M | -$38.8M | -$60.0M | -$103.2M | -$123.5M |
| EBITDA | -$10.5M | -$31.9M | -$69.5M | -$50.4M | -$45.9M | -$40.5M | -$38.0M | -$59.1M | -$102.3M | -$118.6M |
| Charges d'Intérêt | $468000 | $1.2M | $11000 | $70000 | $1.5M | $2.3M | $88000 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$11.3M | -$33.4M | -$70.0M | -$78.2M | -$49.6M | -$43.0M | -$38.1M | -$54.7M | -$95.9M | -$118.8M |
| Impôts | -$357000 | -$3.6M | -$8.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$10.9M | -$29.8M | -$61.5M | -$78.2M | -$49.6M | -$43.0M | -$38.1M | -$54.7M | -$95.9M | -$118.8M |
| BPA | $-3.27 | $-1.70 | $-1.85 | $-2.62 | $-0.84 | $-0.32 | $-0.25 | $-0.33 | $-0.48 | $-0.53 |
| BPA Dilué | $-3.27 | $-1.70 | $-1.85 | $-2.62 | $-0.84 | $-0.32 | $-0.25 | $-0.33 | $-0.48 | $-0.53 |
| Actions en Circulation (Diluées) | $3.3M | $17.5M | $33.3M | $40.0M | $59.3M | $133.9M | $152.8M | $165.2M | $198.2M | $222.4M |
Prix
| Prix | $5.13 |
| Capitalisation | $1.1B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: BCAX · EYPT · GERN · GHRS · KURA · NBTX · PROK
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SVRA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions